NCT03236831

AKI Prevention and Early Intervention in Patients Undergoing VAD Placement

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 210 (actual)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The investigators are doing this research to find out if more careful assessment and elimination of potential risk factors of acute kidney injury (AKI) during the subject's perioperative period will reduce their chance of kidney damage and kidney damage related problems.

Detailed description

The purpose of the study is to investigate whether preventive measures for patients undergoing ventricular assist device (VAD) placement will reduce AKI occurrence, progression and associated complications. Participants will be in the study for a total of 6 days (1 day prior to the surgery and 5 days after the surgery). The investigators will review the participant's medical record up to one year after surgery. The study investigators will access the participant's electronic medical record 24 hours prior to the planned VAD implantation and review the participant's medication regimen and provide recommendations to the participant's primary care physician in an effort to minimize potential risks for AKI. There will be no intervention during the operation. The clinical recommendations will cover the following: 1. Avoidance of potentially nephrotoxic agents. 2. Optimizing volume status (avoidance of volume overload or depletion) 3. Optimizing electrolytes and acid-base status 4. Minimizing IV contrast exposure when appropriate 5. Treating severe anemia 6. Optimization of hemodynamics (Mean arterial BP\>65mmHg). The investigators plan to compare the results of this study with the historical data in the same patient population in the years of 7/1/2015-6/30/2017.

Conditions

• Kidney Injury

Interventions

Type	Name	Description
OTHER	Clinical Recommendations	The investigators will provide clinical recommendations to the subject's primary care provider. These will be in regards to the following: 1. Avoidance of potentially nephrotoxic medications. 2. Optimizing volume status (avoidance of volume overload or depletion) 3. Optimizing electrolytes and acid-base status 4. Minimizing IV contrast exposure when appropriate 5. Treating severe anemia 6. Optimization of hemodynamics (Mean arterial BP\>65mmHg)

Timeline

• Start date: 2017-04-11
• Primary completion: 2019-02-17
• Completion: 2019-02-17
• First posted: 2017-08-02
• Last updated: 2019-10-10

Locations

1 site across 1 country: United States